bioMérieux S.A. (ENXTPA: BIM)
Health Care · Health Care Equipment & Supplies · FR
€84.05
+1.02% today · -27.3% 1Y
bioMérieux S.A. (ENXTPA: BIM) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $10.96B and employs 14,894 people.
Over the last twelve months the share price has lost 27.3%, trading between 65.60 and 116.10.
Tweenvest scores bioMérieux S.A. across four factors: quality 86/100, value 79/100, growth 47/100, dividend 61/100. Its strongest factor is quality.
BIM price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $10.96B
- Revenue (TTM)
- $4.56B
- P/E
- 21.33
- EPS
- 3.90
- Dividend yield
- 1.22%
- Beta (5Y)
- 0.55
- 52-week high
- €116.10
- 52-week low
- €65.60
- Avg volume (3M)
- —
- Shares outstanding
- 117.69M
- Employees
- 14,894
- Next earnings
- —
About bioMérieux S.A.
bioMérieux S.A. is a global entity operating across the Americas, Europe, the Middle East, Africa, and the Asia Pacific, specializing in the development and production of in vitro diagnostic solutions. The company's sophisticated systems utilize biological samples to identify infectious diseases, cardiovascular conditions, and various forms of cancer. Additionally, bioMérieux provides essential microbiological testing services for the manufacturing sectors, primarily serving the food, pharmaceutical, cosmetics, and veterinary industries. Its client base includes clinical and hospital laboratories, medical practitioners, blood banks, and industrial quality control facilities. Founded in 1963, originally under the name B-D Mérieux, bioMérieux S.A. maintains its headquarters in Marcy l'Etoile, France, and functions as a subsidiary of Institut Mérieux SA.
- ISIN
- FR0013280286
- Founded
- 1963
- Listed since
- Jul 7, 2004
- Exchange
- Euronext Paris
- Currency
- EUR
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Shanghai United Imaging Healthcare Co., Ltd.SHSE: 688271 | $13.15B | CN¥107.78 | +0.38% |
| Baxter International Inc.NYSE: BAX | $12.59B | $24.61 | +1.05% |
| Penumbra, Inc.NYSE: PEN | $12.58B | $320.27 | +0.27% |
| Smith & Nephew plcLSE: SN. | $11.36B | £10.21 | +1.69% |
| Demant A/SCPSE: DEMANT | $10.78B | Dkr350.80 | +2.81% |
| The Cooper Companies, Inc.NasdaqGS: COO | $10.34B | $55.45 | +1.99% |
| Align Technology, Inc.NasdaqGS: ALGN | $10.14B | $143.13 | +0.29% |
| Globus Medical, Inc.NYSE: GMED | $10.02B | $75.78 | +1.51% |
Figures last refreshed Oct 11, 2026.